Natasha Ivanova

Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy

Jana Tchekalarova, Natasha Ivanova, Daniela Pechlivanova et al. · Pharmacology Biochemistry and Behavior · 2014 · 54 citations

Kainate Model, Neurobiology Of Disease, Neurophysiology +11

Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy

Jana Tchekalarova, Natasha Ivanova, Dimitrinka Atanasova et al. · Cellular and Molecular Neurobiology · 2015 · 49 citations · Full text

Hypertension, Neurophysiology, Psychotropic Medication +10

Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light

Jana Tchekalarova, Lidia Kortenska, Natasha Ivanova et al. · Psychopharmacology · 2019 · 29 citations

Optogenetics, Sleep, Bdnf Expression +15

Losartan suppresses the kainate-induced changes of angiotensin AT 1 receptor expression in a model of comorbid hypertension and epilepsy

Dimitrinka Atanasova, Jana Tchekalarova, Natasha Ivanova et al. · Life Sciences · 2017 · 20 citations

Molecular Pharmacology, Hypertension, Sodium Homeostasis +10

The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ1-42 Rat Model with Pinealectomy

Rumiana Tzoneva, Irina Georgieva, Natasha Ivanova et al. · International Journal of Molecular Sciences · 2021 · 19 citations · Full text